Complex Immunotherapy-mediated Response Patterns Depicted on Serial 18F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab Therapy

Over the past decade, the role of 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in assessing treatment response for lymphoma patients undergoing immunotherapy has been extensively investigated. The advent of immunotherapy has challenged the utility of the...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohanad Badarneh, Ahmed Abdlkadir, Mohammad Makoseh, Alaa Abufara, Akram Al-Ibraheem
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2025-07-01
Series:Asia Oceania Journal of Nuclear Medicine and Biology
Subjects:
Online Access:https://aojnmb.mums.ac.ir/article_25943_d75fe98ed83c58462cb6fbc2242352a3.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849473429888040960
author Mohanad Badarneh
Ahmed Abdlkadir
Mohammad Makoseh
Alaa Abufara
Akram Al-Ibraheem
author_facet Mohanad Badarneh
Ahmed Abdlkadir
Mohammad Makoseh
Alaa Abufara
Akram Al-Ibraheem
author_sort Mohanad Badarneh
collection DOAJ
description Over the past decade, the role of 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in assessing treatment response for lymphoma patients undergoing immunotherapy has been extensively investigated. The advent of immunotherapy has challenged the utility of the established Lugano criteria, prompting the development of novel immunotherapy-specific response criteria now employed in clinical practice. Following 18F-FDG PET/CT evaluation after up to eight immunotherapy cycles, patients are typically transitioned to conventional imaging modalities if immunotherapy continuation is warranted. This case report illustrates the application of serial 18F-FDG PET/CT in monitoring a 67-year-old patient with Hodgkin lymphoma receiving immunotherapy, revealing complex, atypical response patterns unresolved by existing criteria. Notably, two episodes of pseudoprogression occurred at two distinct time points, one during cycle 5 and the other during cycle 22. Furthermore, an immunotherapy-enhanced abscopal effect was seen during radio-immunotherapy, leading to short-term disease remission. Our findings suggest that 18F-FDG PET/CT provides superior predictive value in delineating heterogeneous response patterns, thereby informing critical decisions regarding immunotherapy cessation or adjunctive therapeutic interventions.
format Article
id doaj-art-ec09ace5b7d14a4ba5572bee2b135b95
institution Kabale University
issn 2322-5718
2322-5726
language English
publishDate 2025-07-01
publisher Mashhad University of Medical Sciences
record_format Article
series Asia Oceania Journal of Nuclear Medicine and Biology
spelling doaj-art-ec09ace5b7d14a4ba5572bee2b135b952025-08-20T03:24:08ZengMashhad University of Medical SciencesAsia Oceania Journal of Nuclear Medicine and Biology2322-57182322-57262025-07-0113218518910.22038/aojnmb.2025.86889.162125943Complex Immunotherapy-mediated Response Patterns Depicted on Serial 18F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab TherapyMohanad Badarneh0Ahmed Abdlkadir1Mohammad Makoseh2Alaa Abufara3Akram Al-Ibraheem4Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, JordanDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, JordanDepartment of Medicine, King Hussein Cancer Center (KHCC), Amman, JordanDepartment of Medicine, King Hussein Cancer Center (KHCC), Amman, JordanDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, JordanOver the past decade, the role of 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) in assessing treatment response for lymphoma patients undergoing immunotherapy has been extensively investigated. The advent of immunotherapy has challenged the utility of the established Lugano criteria, prompting the development of novel immunotherapy-specific response criteria now employed in clinical practice. Following 18F-FDG PET/CT evaluation after up to eight immunotherapy cycles, patients are typically transitioned to conventional imaging modalities if immunotherapy continuation is warranted. This case report illustrates the application of serial 18F-FDG PET/CT in monitoring a 67-year-old patient with Hodgkin lymphoma receiving immunotherapy, revealing complex, atypical response patterns unresolved by existing criteria. Notably, two episodes of pseudoprogression occurred at two distinct time points, one during cycle 5 and the other during cycle 22. Furthermore, an immunotherapy-enhanced abscopal effect was seen during radio-immunotherapy, leading to short-term disease remission. Our findings suggest that 18F-FDG PET/CT provides superior predictive value in delineating heterogeneous response patterns, thereby informing critical decisions regarding immunotherapy cessation or adjunctive therapeutic interventions.https://aojnmb.mums.ac.ir/article_25943_d75fe98ed83c58462cb6fbc2242352a3.pdfpet/ct18f-fdgimmunotherapyabscopal effectpseudoprogression
spellingShingle Mohanad Badarneh
Ahmed Abdlkadir
Mohammad Makoseh
Alaa Abufara
Akram Al-Ibraheem
Complex Immunotherapy-mediated Response Patterns Depicted on Serial 18F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab Therapy
Asia Oceania Journal of Nuclear Medicine and Biology
pet/ct
18f-fdg
immunotherapy
abscopal effect
pseudoprogression
title Complex Immunotherapy-mediated Response Patterns Depicted on Serial 18F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab Therapy
title_full Complex Immunotherapy-mediated Response Patterns Depicted on Serial 18F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab Therapy
title_fullStr Complex Immunotherapy-mediated Response Patterns Depicted on Serial 18F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab Therapy
title_full_unstemmed Complex Immunotherapy-mediated Response Patterns Depicted on Serial 18F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab Therapy
title_short Complex Immunotherapy-mediated Response Patterns Depicted on Serial 18F-FDG PET imaging of Hodgkin Lymphoma Patient Undergoing Pembrolizumab Therapy
title_sort complex immunotherapy mediated response patterns depicted on serial 18f fdg pet imaging of hodgkin lymphoma patient undergoing pembrolizumab therapy
topic pet/ct
18f-fdg
immunotherapy
abscopal effect
pseudoprogression
url https://aojnmb.mums.ac.ir/article_25943_d75fe98ed83c58462cb6fbc2242352a3.pdf
work_keys_str_mv AT mohanadbadarneh compleximmunotherapymediatedresponsepatternsdepictedonserial18ffdgpetimagingofhodgkinlymphomapatientundergoingpembrolizumabtherapy
AT ahmedabdlkadir compleximmunotherapymediatedresponsepatternsdepictedonserial18ffdgpetimagingofhodgkinlymphomapatientundergoingpembrolizumabtherapy
AT mohammadmakoseh compleximmunotherapymediatedresponsepatternsdepictedonserial18ffdgpetimagingofhodgkinlymphomapatientundergoingpembrolizumabtherapy
AT alaaabufara compleximmunotherapymediatedresponsepatternsdepictedonserial18ffdgpetimagingofhodgkinlymphomapatientundergoingpembrolizumabtherapy
AT akramalibraheem compleximmunotherapymediatedresponsepatternsdepictedonserial18ffdgpetimagingofhodgkinlymphomapatientundergoingpembrolizumabtherapy